s6y
Company name or ticker
Search
Dyne Therapeutics, Inc.
144
Filing for proposed sale of securities under Rule 144
Filed
Monday, July 6, 2026
Accession number
0001628280-26-047355
Documents
primary_doc.xml
144
EX-99
EX-99
On sec.gov
Filing index
All files
Complete submission text
SGML header